The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
about
Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis.Update on ankylosing spondylitis: current concepts in pathogenesis.Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of ASDiagnostics of Sacroiliitis According to ASAS Criteria: A Comparative Evaluation of Conventional Radiographs and MRI in Patients with a Clinical Suspicion of Spondyloarthropathy. Preliminary Results.CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responsesClinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab.Assessing patient-centered care in patients with chronic health conditions attending chiropractic practice: protocol for a mixed-methods studyNeutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.Golimumab for the treatment of axial spondyloarthritis.Geographic Variation in Diagnostic Ability and Quality of Care Metrics: A Case Study of Ankylosing Spondylitis and Low Back Pain.Identifying Axial Spondyloarthritis in Electronic Medical Records of US Veterans.Spondyloarthropathies: EULAR recommendations reflect advances in imaging.Association of β-defensin gene copy number variations with ankylosing spondylitis in Chinese population: A case-control study.Association of KIF21B genetic polymorphisms with ankylosing spondylitis in a Chinese Han population of Shandong Province.Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up.Effect of metformin on ossification and inflammation of fibroblasts in ankylosing spondylitis: An in vitro study.The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis.Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis InceptionRegulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity.Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria.
P2860
Q33833623-A89D6ED2-6117-46BA-A07E-15CD9C659774Q34450732-C4CB791E-3BBF-49E7-8B14-5261BB66F404Q34707552-62D5AD93-C05B-4BF0-B258-04E8BF310767Q35648115-0225022E-6025-46FF-84BD-FBCE0C72C694Q36008355-C294FD90-9AA1-4D65-BE59-9554019971E3Q36300483-CBDE729A-BFB8-4EA2-97B6-6272F3718485Q36882478-45E53705-7305-469C-B1DF-A1244008E847Q37296336-1EDD3480-9BF3-4A18-B491-289C0BCBADF9Q38622217-D857A8D7-B260-4758-9E46-FA433C6D6BB6Q38761845-C8C90819-C369-4D09-AF2B-5F27EE69FED2Q39215614-A2C96F07-BB91-4846-9206-BD9D5896FFD1Q41335146-9D8A8136-3F12-4655-9714-3DE59C71E8C4Q41707231-736756BB-5F2C-490B-8F80-C1C41FE66059Q44426919-BDBBBCA8-2C08-4015-9F7F-5FC7D190C6BFQ47400940-E92B99F3-B98F-45F6-AF8F-393CEFE2D752Q47938544-936A1B80-191B-4E71-9554-07707A642EE6Q50065421-537C3EBB-57DC-49CA-AE8E-A38AE13FE279Q53489782-8D4B42C5-466B-4708-9160-5EA391A4404BQ55260956-5EB9A31E-6B5E-48CE-B375-61EC9644449BQ55347433-396682AB-7F79-486E-9680-29B441152803
P2860
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@ast
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@en
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@nl
type
label
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@ast
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@en
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@nl
prefLabel
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@ast
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@en
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@nl
P2860
P1476
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States
@en
P2093
John D Reveille
Michael H Weisman
P2860
P304
P356
10.1097/MAJ.0B013E318294457F
P407
P577
2013-06-01T00:00:00Z